Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109778401000001115 | Pyridostigmine bromide 180mg modified-release tablets (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 109778501000001116 | Pyridostigmine bromide 180mg modified-release tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Pyridostigmine bromide 180mg modified-release tablets 1 tablet | Has VMP | False | Pyridostigmine bromide 180mg modified-release tablets | Inferred relationship | Existential restriction modifier | |
| Pyridostigmine bromide 180mg modified-release tablets 100 tablet | Has VMP | False | Pyridostigmine bromide 180mg modified-release tablets | Inferred relationship | Existential restriction modifier | |
| Pyridostigmine bromide 180mg modified-release tablets (Special Order) | Is a | False | Pyridostigmine bromide 180mg modified-release tablets | Inferred relationship | Existential restriction modifier | |
| Mestinon retard 180mg tablets (Viatris UK Healthcare Ltd) | Is a | False | Pyridostigmine bromide 180mg modified-release tablets | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR